Jan 11 (Reuters) - Immunomedics Inc:
* IMMUNOMEDICS ANNOUNCES AGREEMENT WITH UNIVERSITY OF WISCONSIN CARBONE CANCER CENTER TO EXPAND SACITUZUMAB GOVITECAN (IMMU-132) INTO PROSTATE CANCER
* IMMUNOMEDICS INC - ‍IMMUNOMEDICS TO FUND PHASE 2 STUDY SPONSORED BY UNIVERSITY OF WISCONSIN​ Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.